You are here

Health

Ivermectin: Higher dose, longer duration still ineffective for COVID, new trial finds

A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn't shorten the time to a sustained recovery from COVID-19.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

XBB.1.5 Omicron subvariant spread to northwest states, now dominant in all US regions

In its new variant estimates today, the Centers for Disease Control and Prevention (CDC) said the XBB.1.5 Omicron subvariant is now dominant the northwestern region, making it the most

Also, the more transmissible variant expanded its footprint in areas where it already dominates, and in the United States as a whole, it accounts for an estimated 80.2% of samples, up steadily from 74.7% the previous week.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Health
howdy folks